Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/medicine-technology-1/ardea-biosciences-reports-recent-accomplishments-and-announces-third-quarter-and-year-to-date-2009-financial-results-6048-2/;msg18067;topicseen) was not found.

Search medicine technology 1 ardea biosciences reports recent accomplishments and announces third quarter and year to date 2009 financial results 6048 2 ;msg18067;topicseen at Google

Search medicine technology 1 ardea biosciences reports recent accomplishments and announces third quarter and year to date 2009 financial results 6048 2 ;msg18067;topicseen at Yahoo

Search medicine technology 1 ardea biosciences reports recent accomplishments and announces third quarter and year to date 2009 financial results 6048 2 ;msg18067;topicseen at Msn

Google
 
Breaking Medicine Technology:Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 2Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 3Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 4Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 5Cantel Medical Reports 85% Increase in Net Income - EPS of $0.37 vs. $0.20 - for Quarter Ended October 31, 2009 on 10% Sales Increase 6Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Daniel K. Spiegelman Elected to Board of Directors of Omeros 2The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 1The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 2The Presidents Council on Physical Fitness and Sports Announces 2009 Lifetime Achievement Award Winners 49257 3Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 1Texas Institute for Surgery at Presbyterian Hospital of Dallas Introduces the First Wireless OR in DFW 49253 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 134 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 234 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 334 Outstanding Teachers and Schools Receive 2410 000 Amgen Award for Science Teaching Excellence 49248 4